My work focuses on biomedical innovation and my research has investigated a diverse range of emergent biotechnologies, such as stem cell therapies and synthetic biology. My primary interest is the impact of genomic science on the diagnostics sector, and I have published extensively on the political economy of diagnostic innovation, with a particular focus on regulatory governance and intellectual property rights.
My research uses an international comparative methodology to explore the
continued salience of national institutions such as regulatory regimes
and healthcare systems, in a bioeconomy which is increasingly
characterised by global governance structures, international scientific
collaborations and transnational flows of capital and scientific labour.
My work is situated at the interface of science and technology studies,
medical sociology, history of medicine, bioethics, innovation studies and
regulatory studies and involves interdisciplinary collaboration with
scholars across the domains of biomedicine, law, politics and public
health. I have long-standing collaborative links with Dr Kathy Liddell,
Director of the Centre for Law, Medicine and Life Sciences at Faculty of
My work combines empirical research with normative analysis of public
policy and commercial strategy. I have produced policy reports for the
European Commission and Health Canada, and in the UK Human Genetics
Commission. I was a member of the Department of Health’s Emerging
Science and Bioethics Advisory Committee from 2012-14, and currently
serve on an external strategy group advising the Medicines and
Healthcare Products Regulatory Agency’s on the EU
regulation for diagnostic devices.